Add like
Add dislike
Add to saved papers

Atypical Ebola virus disease in a rhesus macaque.

Ebola virus (EBOV), strain Makona, infected more than 30,000 people from 2013-2016 in West Africa, among them many health care workers including foreign nationals. Most of the infected foreign nationals were evacuated and treated in their respective home countries resulting in detailed reports of the acute disease following EBOV infection as well as descriptions of symptoms now known as "Post-Ebola Syndrome" which occurred months after the infection. Symptoms associated with this syndrome include uveitis and neurological manifestations. In one of our EBOV-Makona nonhuman primate studies, one animal was euthanized on day 28 after EBOV-Makona infection having completely recovered from the acute disease and cleared EBOV from the blood. During convalescence, the animal developed neurological signs and acute respiratory distress requiring euthanasia. The organ tropism had changed with high virus titers in lungs, brain, eye, and reproductive organs but no virus in liver, spleen and adrenal glands, the typical target organs for acute EBOV infection. This in part reflects sequelae described for EBOV survivors in West Africa albeit developing quicker after recovery from acute disease.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app